Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Profectus BioSciences begins phase I trial of HIV plasmid DNA vaccine

Sep. 19, 2013

Dolutegravir designated as orphan drug in Japan

Sep. 18, 2013

Researchers in China prepare new agents for HIV infection

Aug. 28, 2013

Toyama Chemical Co. presents novel products for HIV infection

Aug. 20, 2013

Canadian government provides funding to expand HIV antibody program

Aug. 14, 2013

FDA approves ViiV Healthcare's Tivicay for treatment of HIV-1

Aug. 14, 2013

FDA approves Alere Determine HIV-1/2 Ag/Ab Combo test

Aug. 12, 2013

PrEP trial to evaluate prevention using antiretroviral drugs in HIV-negative individuals

Aug. 2, 2013

Gilead receives positive opinion from EMA for cobicistat

July 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...